Theranica Bio-Electronics, a Netanya, Israel-based bio-medical technology company developing advanced electroceuticals for migraine and other prevalent diseases, closed its $6M Series A funding.
The round was led by Lightspeed Venture Partners with participation from LionBird and Corundum Open Innovation.
The company intends to use the funds to complete the regulatory process of its first product for acute treatment of migraine and to bring the product to mass production.
Established in 2016 by Alon Ironi, CEO, Ronen Jashek, Slava Barabash and Dr. Shimon Eckhouse, Theranica deploys advanced electronics and wireless communication technologies, combined with recent advancements in the research of neurology, to develop a line of “electroceuticals” – drug-free solutions for a few medical conditions, starting with migraine.
FinSMEs
03/07/2017